Word: sabine
(lookup in dictionary)
(lookup stats)
Dates: during 1970-1979
Sort By: most recent first
(reverse)
...mottoes of a scientist that if something seems too good to be true, there is a high probability that it is not true. Few scientists appreciate the aptness of this more than Dr. Albert Sabin, 68, developer of the live-virus polio vaccine. Eighteen months ago, Sabin declared triumphantly that he and a colleague had found convincing evidence that the ubiquitous herpes simplex viruses, which cause cold sores and genital infections, also cause human cancers. Since then, Sabin has been unable to reproduce the earlier laboratory findings. As a result, he is publishing in the Proceedings of the National Academy...
...Sabin based his original indictment on research that he and Dr. Giulio Tarro, 36, of the University of Naples had conducted between 1967 and 1973. The study, signed jointly by Sabin and Tarro, found antibodies produced in the body in reaction to the presence of the herpes simplex Type I and Type II viruses in patients with cancers of the lip, mouth, nose and throat, kidney, bladder, prostate, cervix and vulva. It turned up no trace of the viruses in patients with 28 other malignancies, or in patients without cancer...
...Sabin's claims created an immediate controversy. But it was not until Sabin decided to recheck their experiments himself that he realized why. He was unable to duplicate the earlier results. His failure, he says, left him no other choice than to publish a retraction. "I've been a scientist too long not to do it," he said. "If I find something that a colleague and I have reported that I cannot confirm, it's my duty to report...
Circumstantial Evidence. Sabin's retraction comes as something of a shock to Tarro, who is now in Italy continuing his work. Tarro insists that others -including several U.S. researchers -have duplicated his results and says that he plans to present proof of their validity at international meetings in Germany and Italy next month...
...cleaning up Storrow Lagoon next summer. The plant will treat water already in the Charles with chemicals that bind with river water "to form a matrix in a fluffy kind of stuff," as Noss put it. There's some skepticism as to how well the plant will work: Sabin Lord, the engineer in charge of the lower Charles, has said he thinks the Metropolitain District Commission was sold a bill of goods. There are also as yet unapproved plans for a $500,000 plant in the Basin, which could handle four times as much polluted water as its competitor...